Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Matthew Gabler

Physician Assistant Covington, LA Physician Assistant

NPI 1700075389 CMS profile 10750888

39 Starbrush Cir, Covington, LA 70433

Open in the dashboard

General payments

$9,563

548 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Gabler of Covington, LA is reported in the CMS Open Payments database as having received $9,563 across 548 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,405 76
2024 General $1,718 88
2023 General $1,514 95
2022 General $1,958 131
2021 General $2,967 158

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Gabler
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Matthew Gabler were reported at $1,405. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Matthew Gabler Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,967 $132 $37–$438 $132
2022 $1,958 $155 $48–$522 $149
2023 $1,514 $167 $52–$557 $160
2024 $1,718 $178 $55–$600 $164
2025 $1,405 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $1,914 110 payments
  2. Amgen Inc. $1,026 94 payments
  3. Esperion Therapeutics, Inc. $666 44 payments
  4. Merck Sharp & Dohme Corporation $656 46 payments
  5. Janssen Pharmaceuticals, Inc $565 33 payments
  6. Impulse Dynamics (USA) Inc. $520 5 payments
  7. E.R. Squibb & Sons, L.L.C. $505 30 payments
  8. Pfizer Inc. $453 28 payments
  9. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $413 16 payments
  10. Amarin Pharma Inc. $338 19 payments
  11. Other $2,506 123 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,873 540 payments
  2. Education $389 7 payments
  3. Consulting Fee $300 1 payment
Products named General payments · program years 2021–2025
  1. Repatha $938 89 payments
  2. ENTRESTO $884 55 payments
  3. VERQUVO $759 52 payments
  4. NEXLETOL $666 44 payments
  5. LEQVIO Cardiology/Vascular Diseases $607 45 payments
  6. XARELTO $565 33 payments
  7. Optimizer Smart System $482 3 payments
  8. ELIQUIS $453 28 payments
  9. LifeVest $413 16 payments
  10. LEQVIO Cardiovascular $344 11 payments
  11. Other $4,393 242 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

548 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record